Amneal Pharmaceuticals (AMRX) Exchange Rate Effect (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Exchange Rate Effect of -$1.0 million for Q1 2026, down 117.66% year-over-year from $5.8 million in Q1 2025, and down 389.47% quarter-over-quarter from -$209000.0 in Q4 2025.
Amneal Pharmaceuticals (AMRX) Exchange Rate Effect (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Exchange Rate Effect history runs 10 years deep, the most recent figure standing at -$1.0 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 117.66% year-over-year to -$1.0 million; the TTM figure through Mar 2026 stood at -$2.2 million (down 71.24% YoY), while the FY2025 annual figure was -$1.7 million, down 68.17% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$1.0 million, down from -$209000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $767000.0 in Q1 2023, with the low at -$3.7 million in Q4 2022.
- The 5-year median for Exchange Rate Effect is -$307000.0 (2025), against an average of -$548235.3.
- The sharpest annual moves came in 2023 and 2025: Exchange Rate Effect jumped 148.79% in 2023, then sank 10014.29% in 2025.
- Amneal Pharmaceuticals' Exchange Rate Effect stood at -$3.7 million in 2022, then soared by 105.38% to $201000.0 in 2023, then plunged by 468.16% to -$740000.0 in 2024, then surged by 71.76% to -$209000.0 in 2025, then plunged by 389.47% to -$1.0 million in 2026.
- Business Quant data shows AMRX's Exchange Rate Effect at -$1.0 million in Q1 2026, -$209000.0 in Q4 2025, and -$694000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.49 Bn | 43.53 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.67 Bn | 40.02 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 32.27 Bn | 30.60 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 21.96 Bn | 19.29 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.99 Bn | 18.10 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.75 Bn | 5.62 Bn | 334.51 Mn | -164,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -164,000.00 |
| Jun 30, 2026 | -164,000.00 |
| Mar 31, 2026 | -1.02 Mn |
| Mar 31, 2026 | -1.02 Mn |
| Dec 31, 2025 | -209,000.00 |
| Dec 31, 2025 | -209,000.00 |
| Sep 30, 2025 | -694,000.00 |
| Sep 30, 2025 | -694,000.00 |
| Jun 30, 2025 | -307,000.00 |
| Jun 30, 2025 | -307,000.00 |
| Mar 31, 2025 | -470,000.00 |
| Mar 31, 2025 | -470,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Dec 31, 2024 | -740,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Mar 31, 2024 | -165,000.00 |
| Mar 31, 2024 | -165,000.00 |